Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17545704 | 0.91 | CA2 (0.36) | SCN9AALDH1A1CA2 | |
| SCHEMBL17545714 | 0.86 | KMT2A (0.42) | ALDH1A1GAA | |
| SCHEMBL17545699 | 0.82 | SCN9A (0.36) | SCN9AALDH1A1GAA | |
| SCHEMBL2880584 | 0.75 | SCN9A (0.33) | SCN9A | |
| SCHEMBL21876326 | 0.74 | SCN9A (0.38) | SCN9AALDH1A1GAACA2 | |
| SCHEMBL21876327 | 0.74 | SCN9A (0.38) | SCN9AALDH1A1GAACA2 | |
| SCHEMBL16106772 | 0.74 | SCN9A (0.38) | SCN9AALDH1A1GAACA2 | |
| SCHEMBL686567 | 0.74 | SCN9A (0.39) | SCN9AALDH1A1GAACA2 | |
| SCHEMBL18467219 | 0.74 | SCN9A (0.39) | SCN9AALDH1A1GAACA2 | |
| SCHEMBL17545689 | 0.73 | KMT2A (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9599897-B2 | Salt, resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20160052877-A1 | SALT, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160052877-A1 | SALT, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, AFF1, FRG1 | SCN9A 1125/4885ALDH1A1 2206/4885GAA 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.